Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Week Multicenter, Open-label, Observational Study to Evaluate the Effectiveness of Montelukast Sodium (Singulair®), 4 or 5 mg/Day in Pediatric Subjects With Uncontrolled Asthma

NCT00832455 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00832455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00832455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Week Multicenter, Open-label, Observational Study to Evaluate the Effectiveness of Montelukast Sodium (Singulair®), 4 or 5 mg/Day in Pediatric Subjects With Uncontrolled Asthma
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2006
Completion date
October 31, 2008
Enrollment
445 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma